Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy.
Alcazer V, Bonaventura P, Tonon L, Michel E, Mutez V, Fabres C, Chuvin N, Boulos R, Estornes Y, Maguer-Satta V, Geistlich K, Viari A, Metzeler KH, Hiddemann W, Batch AMN, Herold T, Caux C, Depil S. Alcazer V, et al. Among authors: estornes y. Am J Hematol. 2022 Sep;97(9):1200-1214. doi: 10.1002/ajh.26647. Epub 2022 Jul 12. Am J Hematol. 2022. PMID: 35759575 Free PMC article.
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy.
Bonaventura P, Alcazer V, Mutez V, Tonon L, Martin J, Chuvin N, Michel E, Boulos RE, Estornes Y, Valladeau-Guilemond J, Viari A, Wang Q, Caux C, Depil S. Bonaventura P, et al. Among authors: estornes y. Sci Adv. 2022 Jan 28;8(4):eabj3671. doi: 10.1126/sciadv.abj3671. Epub 2022 Jan 26. Sci Adv. 2022. PMID: 35080970 Free PMC article.
Targeting pattern recognition receptors in cancer immunotherapy.
Goutagny N, Estornes Y, Hasan U, Lebecque S, Caux C. Goutagny N, et al. Among authors: estornes y. Target Oncol. 2012 Mar;7(1):29-54. doi: 10.1007/s11523-012-0213-1. Epub 2012 Mar 8. Target Oncol. 2012. PMID: 22399234 Review.
Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma.
Vanbervliet-Defrance B, Delaunay T, Daunizeau T, Kepenekian V, Glehen O, Weber K, Estornes Y, Ziverec A, Djemal L, Delphin M, Lantuéjoul S, Passot G, Grégoire M, Micheau O, Blanquart C, Renno T, Fonteneau JF, Lebecque S, Mahtouk K. Vanbervliet-Defrance B, et al. Among authors: estornes y. Cancer Lett. 2020 Mar 1;472:29-39. doi: 10.1016/j.canlet.2019.12.016. Epub 2019 Dec 12. Cancer Lett. 2020. PMID: 31838086
Corrigendum to "Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis" [J Hepatol 71 (2019) 763-772].
Bonnin M, Fares N, Testoni B, Estornes Y, Weber K, Vanbervliet B, Lefrançois L, Garcia A, Kfoury A, Pez F, Coste I, Saintigny P, Viari A, Lang K, Guey B, Petrilli V, Hervieu V, Bancel B, Bartosch B, Durantel D, Renno T, Merle P, Lebecque S. Bonnin M, et al. Among authors: estornes y. J Hepatol. 2020 Mar;72(3):594. doi: 10.1016/j.jhep.2019.11.001. Epub 2019 Nov 25. J Hepatol. 2020. PMID: 31780083 No abstract available.
Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis.
Bonnin M, Fares N, Testoni B, Estornes Y, Weber K, Vanbervliet B, Lefrançois L, Garcia A, Kfoury A, Pez F, Coste I, Saintigny P, Viari A, Lang K, Guey B, Hervieu V, Bancel B, Bartoch B, Durantel D, Renno T, Merle P, Lebecque S. Bonnin M, et al. Among authors: estornes y. J Hepatol. 2019 Oct;71(4):763-772. doi: 10.1016/j.jhep.2019.05.031. Epub 2019 Jun 18. J Hepatol. 2019. PMID: 31220470
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis.
Estornes Y, Dondelinger Y, Weber K, Bruggeman I, Peall A, MacFarlane M, Lebecque S, Vandenabeele P, Bertrand MJM. Estornes Y, et al. Cell Death Dis. 2018 May 1;9(5):494. doi: 10.1038/s41419-018-0544-7. Cell Death Dis. 2018. PMID: 29717117 Free PMC article.
20 results